BPC-157 (20 mg Vial) Dosage Protocol

Dosing & Reconstitution Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of a protein found in human gastric juice. The figures below are compiled strictly for laboratory and educational reference — they describe how the compound has been handled and dosed across published animal and early-phase research, not a recommendation for use in humans or animals.

For a 20 mg vial, adding 2.0 mL of bacteriostatic water yields a concentration of 10 mg/mL (10,000 mcg/mL). At that concentration, every 0.01 mL drawn on a U-100 insulin syringe equals 1 unit and delivers 100 mcg of material, so a 200 mcg measurement is simply 2 units — which keeps the arithmetic clean across the titration steps.

Standard (Gradual) Titration Schedule

The gradual schedule mirrors the slow dose-escalation approach reported in the research literature, where the daily amount is stepped up over the first few weeks to establish tolerability at the low end before reaching the working range.

Reconstitution Steps

1. Let the sealed lyophilized vial and the bacteriostatic water reach room temperature, then wipe both stoppers with an alcohol swab.
2. Draw 2.0 mL of bacteriostatic water and inject it slowly down the inside wall of the vial — never directly onto the powder pellet.
3. Swirl gently until fully dissolved. Do not shake; aggressive agitation can shear the peptide.
4. The solution should be clear and colourless. Label the vial with the concentration (10 mg/mL) and the reconstitution date.
5. Store upright under refrigeration between uses and draw subsequent volumes with a fresh sterile syringe each time.

Advanced (Higher-Volume) Titration Schedule

The advanced schedule reaches the upper bound of the daily research range and holds it for the duration of an extended protocol. Because each dose is small relative to the fill, the entire range stays well within a single syringe and a single vial.

Supplies Needed

• BPC-157 vials (20 mg): ~2 vials for an 8-week daily run; ~3 vials for a 12-week run; ~4 vials for a 16-week run at the upper range.
• Insulin syringes (U-100, 1 mL): 56 for 8 weeks, 84 for 12 weeks, 112 for 16 weeks (one fresh syringe per once-daily draw).
• Bacteriostatic water (10 mL): one bottle covers ~5 vials at 2 mL each, so a single bottle is ample for most runs.
• Alcohol swabs: 112 for 8 weeks, 168 for 12 weeks, 224 for 16 weeks (two to three 100-count boxes).

Protocol Overview

• Research goal: model tissue-repair and cytoprotective signalling in gut, tendon, ligament and muscle injury models.
• Schedule: once-daily subcutaneous administration in the published model.
• Dose band: 200–600 mcg daily.
• Fill: 20 mg lyophilized, reconstituted to 10 mg/mL with 2 mL diluent.
• Storage: −20 °C dry; 2–8 °C once reconstituted.

Dosing Protocol Notes

• Begin at the lowest 200 mcg step and hold each level for about two weeks before escalating.
• Keep administration on a fixed once-daily cadence and the same time of day where possible for steady exposure modelling.
• Escalate only after tolerability is established at the prior step.
• Target the upper band (600 mcg) for the bulk of an extended tissue-repair protocol window.

Storage Instructions

Keep sealed lyophilized vials at −20 °C, protected from light, where stability extends for many months. Once reconstituted, refrigerate at 2–8 °C (about 36–46 °F) and use within roughly four weeks. Allow refrigerated solution to warm slightly before drawing, avoid repeated freeze-thaw cycles, and aliquot if a vial will be sampled many times.

Important Handling Notes

• Use a sterile syringe for every draw and never re-enter the vial with a used needle.
• Rotate sampling/handling technique to keep the stopper intact.
• Because individual doses are very small (2–6 units), draw slowly and read the plunger at eye level to avoid over-pulling.
• Document each draw — date, volume, remaining material — for reproducibility.

How BPC-157 Works

BPC-157 is a stable synthetic peptide corresponding to a fragment of a protective protein isolated from gastric juice. In preclinical models it appears to act on the nitric oxide system and to upregulate growth-factor expression, which together support angiogenesis (new blood-vessel formation) and collagen deposition at sites of injury. Animal studies have reported accelerated repair across gut, tendon, ligament and muscle tissue, alongside anti-inflammatory and cytoprotective effects. Unlike the metabolic incretin peptides, it is studied for local and systemic healing signalling rather than glucose or appetite regulation.

Reported Benefits & Side Effects

Benefits observed in research

• Supports tissue repair in gut, tendon, muscle and skin injury models in animal data.
• Demonstrates anti-inflammatory and cytoprotective properties in preclinical settings.
• Promotes angiogenesis and collagen organisation in healing tissue models.
• Phase I safety work has reported good tolerability with no serious adverse events at the doses tested.

Side effects reported

• Occasional mild injection-site reactions such as redness or itching with subcutaneous administration.
• Long-term human safety and efficacy remain under investigation, with most evidence drawn from animal models.

Supporting Lifestyle Factors (Research Context)

• Adequate protein intake and micronutrient-dense nutrition to supply repair substrate in study designs.
• A balance of activity and rest to allow tissue adaptation between loading sessions.
• Prioritised sleep and stress management as standard controls that influence healing rates.
• Injury-specific rehabilitation guidance from qualified professionals in clinical contexts.

Injection Technique (Reference Only)

• Clean the vial stopper and the site with alcohol swabs and let them dry.
• Pinch a skinfold and insert subcutaneously at a 45–90° angle depending on needle length; aspiration is not required for subcutaneous work.
• Inject slowly and steadily, then withdraw and apply light pressure.
• Rotate sites systematically (abdomen, thighs, upper arms) and dispose of sharps in an approved container.

References

Related Protocols